Your browser doesn't support javascript.
Prevalence and outcomes of hyponatremia among COVID-19 patients: A systematic review and meta-analysis.
Khidir, Reem Jamal Yousif; Ibrahim, Basil Abubakr Yagoub; Adam, Mosab Hussen Mostafa; Hassan, Riyan Mobark Elsiddig; Fedail, Amro Suliman Salih; Abdulhamid, Rabab Osman; Mohamed, Sagad Omer Obeid.
  • Khidir RJY; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Ibrahim BAY; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Adam MHM; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Hassan RME; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Fedail ASS; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Abdulhamid RO; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
  • Mohamed SOO; Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Int J Health Sci (Qassim) ; 16(5): 69-84, 2022.
Article in English | MEDLINE | ID: covidwho-2231856
ABSTRACT

Objectives:

On March 2020, the WHO declared coronavirus disease 2019 (COVID-19) pandemic. COVID-19 is associated with various clinical syndromes, with electrolytes imbalances involved. This review aims to quantify the prevalence and outcomes of hyponatremia among COVID-19 patients, as well as to review the underlying pathophysiological mechanisms of hyponatremia among these patients.

Methods:

Using Preferred Reporting Items for Systematic Reviews and Meta Analyses guidelines, we conducted a systematic literature search using the electronic databases of Google Scholar, MEDLINE (PubMed), WHO Virtual Health Library, and ScienceDirect, without limitations regarding gender, geographical area, race or publication date, up until December 13, 2021. Primary outcomes measured were mortality, intensive care unit (ICU) admission, assisted ventilation need, and length of hospital stay (LOS). Secondary outcome was the mechanism underlying hyponatremia among COVID-19 patients.

Results:

From a total of 52 included studies, 23 underwent quantitative analysis. For the primary outcomes; proportions, odds ratios (OR), and standardized mean difference (SMD) were calculated using random effects model. The prevalence of hyponatremia was found to be 25.8%. Hyponatremia was found to be significantly associated with increased odds for mortality (OR = 1.97[95% CI, 1.50-2.59]), ICU admission (OR = 1.91 [95% CI, 1.56-2.35]), assisted ventilation need (OR = 2.04 [95% CI, 1.73-2.38]), and with increased LOS (SMD of 5.74 h [95% CI, 0.092-0.385]). Regarding the mechanisms underlying hyponatremia, syndrome of inappropriate anti-diuretic hormone secretion (SIADH) was most commonly reported, followed by adrenal insufficiency, and finally hypovolemic hyponatremia due to gastrointestinal losses.

Conclusion:

Hyponatremia among COVID-19 patients is generally associated with poor outcomes, with SIADH being the most common underlying mechanism.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Language: English Journal: Int J Health Sci (Qassim) Year: 2022 Document Type: Article Affiliation country: Sudan

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Language: English Journal: Int J Health Sci (Qassim) Year: 2022 Document Type: Article Affiliation country: Sudan